µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© l(}L-:@A
6-)WXJ@V
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© v-q-CI?B#
1¡¢Co-stimulators (or co-stimulating molecules) fiD,HGx
i
2¡¢NK-kB sK&kp=zu
3¡¢Immunoglobulin superfamily m.1-[ 2{8~
4¡¢antigen-presenting cell (APC) -zqpjxU:
5¡¢death domain tY!l}:E[
6¡¢CCR and CXCR '<uM\v^k
7¡¢Lectin (or mitogen) \b8#x
T}
8¡¢Clusters of differentiation, CD) q 5z^y(Sv
9¡¢B7 family j u"?b2f
10¡¢Cytotoxic T lymphocyte, CTL) d
JJq]^|
11¡¢IL-15 and IL-15 receptor (IL-15R) 6DK).|@$r
12¡¢MHC restriction gW--[
13¡¢Affinity-chromatography d^!k{Qx'
14¡¢Cyctosprin A, CsA W;UPA~nT~
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) Fw{@RQf8
n8_X<jIp3
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© ]sL.+.P
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
<HN+pi
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ ]BjYUTNm
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 S#B%[3@
bPP@
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© L[Z^4l_!
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ .ve_If-Hg
ѪҺ²¡Ñ§×¨Òµ£º A:GqR;;"x>
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿